Experienced in Hemolytic Anemia

Tong J. Zhou

Key Laboratory Of Carcinogenesis And Translational Research, 
Beijing, CN 
Experienced in Hemolytic Anemia
Key Laboratory Of Carcinogenesis And Translational Research, 
Beijing, CN 
OverviewLocationsClinical Research

Overview

Tong Zhou practices in Beijing, China. Mr. Zhou is rated as an Experienced expert by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Stomach Cancer, Sarcoidosis, Familial Colorectal Cancer, Osteotomy, and Endoscopy.

His clinical research consists of co-authoring 840 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hemolytic Anemia.

Gender
Male

Locations

Key Laboratory Of Carcinogenesis And Translational Research, Beijing, China
Other Locations
Union Hospital, Wuhan, 430022, China
No. 11 Fu Cheng Road, Haidian, 100048, China
Xiangya Road 110, Changsha, 410078, China
Yangtze River Fisheries Research Institute, Wuhan, China
1-1 Zhongfu Road, Nanjing, 210003, China
NO.21 North Jianshe Road, Tangshan, 063000, China
483 Wushan Road, Guangzhou, 510642, China
No. 461 Ba Yi Avenue, Nanchang, 330006, China
1School Of Bioengineering, No. 2 Linggong Road, Dalian, 116024, China
NO.139 Ziqiang Road, Shijiazhuang, 050051, China
305 Fenglin Road, Shanghai, 200032, China
No.16 Xuelin Road, Xiasha Higher Education Park, Hangzhou, China
61 Daizong Street, 271018, China
No. 197, Rui Jin Er Road, Shanghai, 200025, China
State Key Laboratory Of Drug Research, Shanghai, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An Exploratory Study of Low-dose Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer
An Exploratory Study of Low-dose Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: December 10, 2019
Intervention Type: Drug
Study Phase: Phase 2

840 Total Publications

Mutual-Activation between Doped Pt-Single-Atoms and Basal-Plane Sites in 1T-TaS2 Nanosheets Networks for Highly Efficient Hydrogen Evolution.
Mutual-Activation between Doped Pt-Single-Atoms and Basal-Plane Sites in 1T-TaS2 Nanosheets Networks for Highly Efficient Hydrogen Evolution.
Journal: ACS nano
Published: October 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Zhou's expertise for a condition
ConditionClose
      View All 14 Advanced Conditions
      View All 81 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile